ilmscore | Prediction Details
"we should be the second after Lily if Danel progress into registration enabling St"
By Stock Market Live | July 30, 2024 | Pending
From video
MSFT & AMD EARNINGS 02:26:59 - 02:27:06
Interpreted Prediction
Pfizer (PFE) expects to be the second company after Eli Lilly (LLY) to bring an oral GLP-1 (Danuglipron) to market if it progresses through registration studies.

Prediction Details

Ticker
PFE

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.